{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T08:33:14Z","timestamp":1777883594991,"version":"3.51.4"},"reference-count":29,"publisher":"SAGE Publications","issue":"4","license":[{"start":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T00:00:00Z","timestamp":1750896000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"DOI":"10.13039\/100011221","name":"Heersink School of Medicine, University of Alabama at Birmingham","doi-asserted-by":"publisher","award":["UL1TR003096"],"award-info":[{"award-number":["UL1TR003096"]}],"id":[{"id":"10.13039\/100011221","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Substance Use &amp; Addiction Journal"],"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:p>With the ongoing drug crisis, serious injection-related infections (SIRIs), such as endocarditis, have increased significantly. Hospitalizations are a missed opportunity for persons who inject drugs (PWID) to engage in care. We developed a 5-item SIRI Checklist for providers as a standardized reminder to offer medication for opioid use disorder (MOUD), human immunodeficiency virus (HIV), and hepatitis C virus (HCV) screening, harm reduction, and referral to community-based care. We formalized an Intensive Peer Recovery Coach protocol to support PWID on discharge. We hypothesized that the SIRI Checklist and Intensive Peer Intervention would increase HIV and HCV screening, MOUD, and linkage to care: pre-exposure prophylaxis (PrEP) prescription, MOUD prescription, and related outpatient visit(s). This is a feasibility study and randomized control trial of a Checklist and Intensive Peer intervention for hospitalized PWID with SIRI. We will randomize 60 PWID into 4 groups (SIRI Checklist, SIRI Checklist\u2009+\u2009Intensive Peer, Intensive Peer, and Standard of Care). Results will be analyzed using a 2\u2009\u00d7\u20092 factorial design. Outcomes include the ability to recruit and retain hospitalized PWID and clinical data (HIV, HCV testing, MOUD, and PrEP prescriptions). By testing low-barrier interventions that are accessible and reproducible in a rural, poor state, we aim to identify models of care that promote linkage and engagement in community care.<\/jats:p>","DOI":"10.1177\/29767342251339291","type":"journal-article","created":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T10:41:32Z","timestamp":1750934492000},"page":"1047-1052","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["A Study Protocol to Increase Engagement in Evidence-Based Hospital and Community-Based Care Using a Serious Injection-Related Infections Checklist and Intensive Peer for Hospitalized PWID (ShaPe)"],"prefix":"10.1177","volume":"46","author":[{"given":"Margaret","family":"Baldwin","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases, University of Alabama at Birmingham, Heersink School of Medicine, Birmingham, AL, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madison","family":"Jeziorski","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, University of Alabama at Birmingham, Heersink School of Medicine, Birmingham, AL, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariel","family":"Parman","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, University of Alabama at Birmingham, Heersink School of Medicine, Birmingham, AL, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelly W.","family":"Gagnon","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, University of Alabama at Birmingham, Heersink School of Medicine, Birmingham, AL, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alana C.","family":"Nichols","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, University of Alabama at Birmingham, Heersink School of Medicine, Birmingham, AL, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Davis","family":"Bradford","sequence":"additional","affiliation":[{"name":"General Internal Medicine, University of Alabama at Birmingham, Heersink School of Medicine, Birmingham, AL, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaylee","family":"Crockett","sequence":"additional","affiliation":[{"name":"Family &amp; Community Medicine, University of Alabama at Birmingham, Heersink School of Medicine, Birmingham, AL, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8539-4907","authenticated-orcid":false,"given":"Ellen F.","family":"Eaton","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, University of Alabama at Birmingham, Heersink School of Medicine, Birmingham, AL, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2025,6,26]]},"reference":[{"key":"e_1_3_3_2_2","unstructured":"Data from: Alabama HIV and AIDS Quarterly Statistics. Archived Statistics | Alabama Department of Public Health (ADPH). 2017. Accessed July 12 2024."},{"key":"e_1_3_3_3_2","unstructured":"Weiss AJ Elixhauser A Barrett ML Steiner CA Bailey MK O\u2019Malley L. Opioid-Related Inpatient Stays and Emergency Department Visits by State 2009-2014. 2016. Accessed July 12 2024. https:\/\/www.hcup-us.ahrq.gov\/reports\/statbriefs\/sb219-Opioid-Hospital-Stays-ED-Visits-by-State.pdf"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofw157"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciac543"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy722"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiaa129"},{"key":"e_1_3_3_8_2","article-title":"In-Hospital Illicit Drug Use and Patient-Directed Discharge: Barriers to Care for Patients With Injection-Related Infections","author":"Eaton EF","year":"2020","unstructured":"Eaton EF, Westfall AO, McClesky B, et al. In-Hospital Illicit Drug Use and Patient-Directed Discharge: Barriers to Care for Patients With Injection-Related Infections. Oxford University Press US; 2020:ofaa074.","journal-title":"Oxford University Press US"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiaa005"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000000496"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2018.08.029"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6806a4"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000001098"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2019.6390"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11904-010-0063-3"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1089\/apc.2018.0126"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-014-0890-0"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2018.06.011"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy924"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.17226\/256262019"},{"key":"e_1_3_3_21_2","unstructured":"Am I Rural?-Tool. Rural health information hub. Accessed July 14 2024. https:\/\/www.ruralhealthinfo.org\/am-i-rural"},{"key":"e_1_3_3_22_2","volume-title":"Presented at: Conference on Retroviruses and Opportunistic Infections 2019","author":"Eaton E","unstructured":"Eaton E, Westfall A, Mathews R. Interdisciplinary intervention for hospitalized PWID may increase MAT use. Presented at: Conference on Retroviruses and Opportunistic Infections 2019; 2019; Seattle, WA."},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-022-07618-x"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-015-0938-1"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0b013e31823779ae"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-048178"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2016.07.032"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2016.02.019"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-10-67"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-019-3578-y"}],"container-title":["Substance Use &amp; Addiction Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/29767342251339291","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/29767342251339291","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/29767342251339291","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T01:51:22Z","timestamp":1777600282000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/29767342251339291"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,26]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["10.1177\/29767342251339291"],"URL":"https:\/\/doi.org\/10.1177\/29767342251339291","relation":{},"ISSN":["2976-7342","2976-7350"],"issn-type":[{"value":"2976-7342","type":"print"},{"value":"2976-7350","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,26]]}}}